We found that CD8+ T cells infiltrating CT2A were more likely to express 4-1BB than CD8+ T cells infiltrating other models, in a manner that appeared to correlate with the efficacy of combination treatment against that tumor. This evidence concerns the gene CD8A and neoplasm.